STRM.BIO is a pre-clinical biotechnology company based in Boston, MA, focusing on gene therapy using extracellular vesicles (EVs). Unlike traditional viral vectors, EVs offer natural targeting capabilities, ease of large-scale production, and low immunogenicity, making them an innovative platform for delivering therapies directly to patients. STRM.BIO aims to democratize gene therapy and treat rare diseases worldwide, leveraging its proprietary EV technology to develop new and enhance existing treatments.
STRM.BIO is a VC-backed biotech startup building a new kind of gene therapy delivery platform based on naturally occurring extracellular vesicles (EVs). We're looking for Scientists to help lead and grow our research engine.
STRM.BIO is a pre-clinical biotechnology company based in Boston, MA, focusing on gene therapy using extracellular vesicles (EVs). Unlike traditional viral vectors, EVs offer natural targeting capabilities, ease of large-scale production, and low immunogenicity, making them an innovative platform for delivering therapies directly to patients. STRM.BIO aims to democratize gene therapy and treat rare diseases worldwide, leveraging its proprietary EV technology to develop new and enhance existing treatments.
Bristol Myers Squibb